The XSTAT hemostatic device was successfully used this week to clot a bleeding soldier's wound, marking the first documented clinical use of the tool.
The XSTAT hemostatic device, designed by RevMedx, was introduced last year. The tool is designed to stop severe bleeding in a matter of seconds in areas of the body that can't be easily treated with a tourniquet, like the armpit or chest.
The device uses a series of small sponges, which are injected into the wounded area with a syringe-like applicator. Once inserted, the sponges expand and exert hemostatic pressure to stop bleeding.
During a seven-hour surgery to save a wounded U.S. soldier shot in the thigh, surgeons struggled to contain the bleeding. After multiple failed attempts at using bone wax and cautery on the wounds, the medical team turned to the XSTAT device. The tool stopped the bleeding within seconds, according to Digital Trends.
"The first-in-human experience with XSTAT is the culmination of tremendous effort on the part of both RevMedx and our military collaborators," said Andrew Barofsky, president and CEO of RevMedx, according to Digital Trends. "We are pleased to see XSTAT play a critical role in saving a patient's life and hope to see significant advancement toward further adoption of XSTAT as a standard of care for severe hemorrhage in pre-hospital settings."
More articles on supply chain:
Scope-cleaning machine tied to super bugs still in use after FDA backs off recall
Medicare's proposed drug pricing plan raises bipartisan concerns
Scientists develop method to 'print' drugs into customizable tablets